| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |